Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
Clinical trial NCT06208137 · RECRUITING
Trial details
- NCT number
- NCT06208137
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2027-10-01
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.